These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 32798438

  • 21. Alpha Globin Gene Mutation: A Major Determinant of Hydroxyurea Response in Transfusion-Dependent HbE-β-Thalassaemia.
    Biswas S, Ray R, Roy K, Bandyopadhyay A, Ghosh K, Bhattacharyya M.
    Acta Haematol; 2019; 142(3):132-141. PubMed ID: 31352439
    [Abstract] [Full Text] [Related]

  • 22. Role of XmnIgG Polymorphism in Hydroxyurea Treatment and Fetal Hemoglobin Level at Isfahanian Intermediate β-Thalassemia Patients.
    Motovali-Bashi M, Ghasemi T.
    Iran Biomed J; 2015; 19(3):177-82. PubMed ID: 26024726
    [Abstract] [Full Text] [Related]

  • 23. Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells.
    Moutouh-de Parseval LA, Verhelle D, Glezer E, Jensen-Pergakes K, Ferguson GD, Corral LG, Morris CL, Muller G, Brady H, Chan K.
    J Clin Invest; 2008 Jan; 118(1):248-58. PubMed ID: 18064299
    [Abstract] [Full Text] [Related]

  • 24. The role of fetal hemoglobin-enhancing agents in thalassemia.
    Lal A, Vichinsky E.
    Semin Hematol; 2004 Oct; 41(4 Suppl 6):17-22. PubMed ID: 15534853
    [Abstract] [Full Text] [Related]

  • 25. Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease.
    Thein SL.
    Adv Exp Med Biol; 2017 Oct; 1013():27-57. PubMed ID: 29127676
    [Abstract] [Full Text] [Related]

  • 26. Common fetal hemoglobin variants in Lebanese patients bearing the codon 29 beta gene mutation associated with different thalassemia phenotypes.
    Brancaleoni V, Moukhadder HM, Consonni D, Koussa S, Di Pierro E, Cappellini MD, Taher A.
    Ann Hematol; 2019 Apr; 98(4):833-840. PubMed ID: 30506348
    [Abstract] [Full Text] [Related]

  • 27. Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia.
    Atweh GF, Loukopoulos D.
    Semin Hematol; 2001 Oct; 38(4):367-73. PubMed ID: 11605172
    [Abstract] [Full Text] [Related]

  • 28. Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line.
    Zein S, Li W, Ramakrishnan V, Lou TF, Sivanand S, Mackie A, Pace B.
    Exp Biol Med (Maywood); 2010 Nov; 235(11):1385-94. PubMed ID: 20975082
    [Abstract] [Full Text] [Related]

  • 29. Interferon-gamma modulates fetal hemoglobin synthesis in sickle cell anemia and thalassemia.
    Miller BA, Olivieri N, Hope SM, Faller DV, Perrine SP.
    J Interferon Res; 1990 Aug; 10(4):357-66. PubMed ID: 1700029
    [Abstract] [Full Text] [Related]

  • 30. Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
    Perrine SP, Castaneda SA, Boosalis MS, White GL, Jones BM, Bohacek R.
    Ann N Y Acad Sci; 2005 Aug; 1054():257-65. PubMed ID: 16339673
    [Abstract] [Full Text] [Related]

  • 31. Interpreting elevated fetal hemoglobin in pathology and health at the basic laboratory level: new and known γ- gene mutations associated with hereditary persistence of fetal hemoglobin.
    Amato A, Cappabianca MP, Perri M, Zaghis I, Grisanti P, Ponzini D, Di Biagio P.
    Int J Lab Hematol; 2014 Feb; 36(1):13-9. PubMed ID: 23621512
    [Abstract] [Full Text] [Related]

  • 32. Effective erythropoiesis and HbF reactivation induced by kit ligand in beta-thalassemia.
    Gabbianelli M, Morsilli O, Massa A, Pasquini L, Cianciulli P, Testa U, Peschle C.
    Blood; 2008 Jan 01; 111(1):421-9. PubMed ID: 17951528
    [Abstract] [Full Text] [Related]

  • 33. Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β0-thalassemia/HbE disease.
    Khamphikham P, Sripichai O, Munkongdee T, Fucharoen S, Tongsima S, Smith DR.
    Int J Hematol; 2018 Mar 01; 107(3):297-310. PubMed ID: 29067594
    [Abstract] [Full Text] [Related]

  • 34. Ginsenoside Rg1 promotes fetal hemoglobin production in vitro: A potential therapeutic avenue for β-thalassemia.
    Cai DL, Chan Y, Kong YM, Liu YZ, Guo Y, Cai AQ, Zhu BS.
    Eur J Pharmacol; 2024 Apr 05; 968():176404. PubMed ID: 38382804
    [Abstract] [Full Text] [Related]

  • 35. Clinical observation on YiSuiShengXueGranule on treating 156 patients with beta-thalassemia major and the molecular mechanism study.
    Fang S, Wu Z, Zhang X, Liu Y, Wang W, Chai L, Cai H, Yi J, Wang L, Chen Y, Lv X, Huang Y, Wang R, Chen P.
    Biol Pharm Bull; 2007 Nov 05; 30(11):2084-7. PubMed ID: 17978480
    [Abstract] [Full Text] [Related]

  • 36. Alpha hemoglobin stabilizing protein: Its causal relationship with the severity of beta thalassemia.
    Sagar CS, Kumar R, Sharma DC, Kishor P.
    Blood Cells Mol Dis; 2015 Aug 05; 55(2):104-7. PubMed ID: 26142324
    [Abstract] [Full Text] [Related]

  • 37. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R.
    Blood Cells Mol Dis; 2009 Aug 05; 42(1):25-31. PubMed ID: 18954999
    [Abstract] [Full Text] [Related]

  • 38. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.
    Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC.
    Haematologica; 2004 Oct 05; 89(10):1172-8. PubMed ID: 15477200
    [Abstract] [Full Text] [Related]

  • 39. UNC0638 induces high levels of fetal hemoglobin expression in β-thalassemia/HbE erythroid progenitor cells.
    Nualkaew T, Khamphikham P, Pongpaksupasin P, Kaewsakulthong W, Songdej D, Paiboonsukwong K, Sripichai O, Engel JD, Hongeng S, Fucharoen S, Jearawiriyapaisarn N.
    Ann Hematol; 2020 Sep 05; 99(9):2027-2036. PubMed ID: 32567028
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.